Literature DB >> 12810420

Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome.

G Medina1, D Casaos, L J Jara, O Vera-Lastra, M Fuentes, L Barile, M Salas.   

Abstract

OBJECTIVE: To investigate the prevalence and clinical significance of carotid artery intima-media thickness (IMT) in patients with primary antiphospholipid syndrome (APS).
METHODS: 28 patients with primary APS with at least a five year follow up, and 28 healthy subjects, matched by age and sex, were included in the study. Colour Doppler with high resolution B mode carotid ultrasonography and spectral analysis were performed in patients and controls. Information on cardiovascular risk factors and the clinical course were collected.
RESULTS: The mean (SD) age of patients and controls (12 male, 16 female in each group) was 40 (8.5) years; the mean (SD) disease duration 7.7 (3) years. Carotid artery IMT was found in 23/28 patients (2.6 (1.14) mm) and 7/28 controls (1.2 (0.44)) (p=0.0001). A decrease in the lumen diameter was also found in 11/28 patients with primary APS without carotid atherosclerotic plaque, and 2/28 controls (p=0.004). Hyperlipidaemia, diabetes, smoking, obesity, and hypertension were not associated with carotid artery IMT. Patients with carotid artery IMT had arterial vascular disease more often than patients without: 9/23 v 0/5 (p<0.009). These patients had stroke (seven patients), myocardial infarction (one), and mesenteric thrombosis (one). Subjects with IMT had a threefold higher risk for stroke than those without IMT (95% CI 0.78 to 14.3).
CONCLUSIONS: Patients with primary APS have a high prevalence of carotid artery IMT and a decreased lumen diameter. IMT in primary APS may be associated with stroke. Patients with primary APS with IMT must be considered as carriers of atherosclerosis.

Entities:  

Mesh:

Year:  2003        PMID: 12810420      PMCID: PMC1754607          DOI: 10.1136/ard.62.7.607

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  23 in total

Review 1.  Accelerated atheroma, antiphospholipid antibodies, and the antiphospholipid syndrome.

Authors:  J George; D Haratz; Y Shoenfeld
Journal:  Rheum Dis Clin North Am       Date:  2001-08       Impact factor: 2.670

2.  [Cardiovascular risk factors and carotid atherosclerosis detected by ultrasonography].

Authors:  C Cantú-Brito; J Rodríguez-Saldaña; M T Reynoso-Marenco; R Marmolejo-Henderson; F Barinagarrementeria-Aldatz
Journal:  Salud Publica Mex       Date:  1999 Nov-Dec

3.  Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.

Authors:  J M Esdaile; M Abrahamowicz; T Grodzicky; Y Li; C Panaritis; R du Berger; R Côte; S A Grover; P R Fortin; A E Clarke; J L Senécal
Journal:  Arthritis Rheum       Date:  2001-10

4.  Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome.

Authors:  M J Roman; J E Salmon; R Sobel; M D Lockshin; L Sammaritano; J E Schwartz; R B Devereux
Journal:  Am J Cardiol       Date:  2001-03-01       Impact factor: 2.778

5.  Severe atherosclerotic changes, including aortic occlusion, associated with hyperhomocysteinaemia and antiphospholipid antibodies.

Authors:  P E Spronk; E H Overbosch; N H Schut
Journal:  Ann Rheum Dis       Date:  2001-07       Impact factor: 19.103

6.  Antiphospholipid arterial vasculopathy.

Authors:  D Alarcón-Segovia; M H Cardiel; E Reyes
Journal:  J Rheumatol       Date:  1989-06       Impact factor: 4.666

7.  Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging.

Authors:  P Pignoli; E Tremoli; A Poli; P Oreste; R Paoletti
Journal:  Circulation       Date:  1986-12       Impact factor: 29.690

8.  Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies.

Authors:  P R J Ames; A Margarita; J Delgado Alves; C Tommasino; L Iannaccone; V Brancaccio
Journal:  Lupus       Date:  2002       Impact factor: 2.911

9.  Complement activation and atherosclerosis.

Authors:  F Niculescu; H Rus
Journal:  Mol Immunol       Date:  1999 Sep-Oct       Impact factor: 4.407

10.  Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study.

Authors:  G Heiss; A R Sharrett; R Barnes; L E Chambless; M Szklo; C Alzola
Journal:  Am J Epidemiol       Date:  1991-08-01       Impact factor: 4.897

View more
  17 in total

1.  Endothelial dysfunction in patients with antiphospholipid syndrome assessed with positron emission tomography.

Authors:  Erick Alexanderson; Patricio Cruz; Angélica Vargas; Aloha Meave; Alejandro Ricalde; Jose A Talayero; José Luis Romero-Ibarra; Tovë M Goldson; Olga L Vera-Lastra; Gabriela Medina; Luis Jara; Mary-Carmen Amigo
Journal:  J Nucl Cardiol       Date:  2007-07-02       Impact factor: 5.952

Review 2.  A critical view on cardiovascular risk in systemic sclerosis.

Authors:  Antonios Psarras; Stergios Soulaidopoulos; Alexandros Garyfallos; George Kitas; Theodoros Dimitroulas
Journal:  Rheumatol Int       Date:  2016-07-12       Impact factor: 2.631

3.  Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice.

Authors:  Victoria Ulrich; Eddy S Konaniah; Wan-Ru Lee; Sadiksha Khadka; Yu-Min Shen; Joachim Herz; Jane E Salmon; David Y Hui; Philip W Shaul; Chieko Mineo
Journal:  J Am Heart Assoc       Date:  2014-10-14       Impact factor: 5.501

4.  Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Effect on carotid intima-media thickness.

Authors:  T A Gheita; H A Raafat; S Sayed; H El-Fishawy; M M Nasrallah; E Abdel-Rasheed
Journal:  Z Rheumatol       Date:  2013-03       Impact factor: 1.372

Review 5.  Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome.

Authors:  Roberta Gualtierotti; Martina Biggioggero; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

Review 6.  Renal manifestations of the antiphospholipid syndrome.

Authors:  David D'Cruz
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

Review 7.  Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings.

Authors:  Hasya Zinger; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

Review 8.  Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome.

Authors:  Paul R J Ames; Annamaria Margarita; Jose Delgado Alves
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

Review 9.  Systemic antiphospholipid syndrome and atherosclerosis.

Authors:  Luis J Jara; Gabriela Medina; Olga Vera-Lastra
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

10.  Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors.

Authors:  Carlos Borelli Zeller; Simone Appenzeller
Journal:  Curr Cardiol Rev       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.